ALXA Financial Facts
Research and development: 6.22MInterest expense: -222K
See Full Income Statement
Total current liabilities: 20.24M
Deferred rent: 7.62M
See Full Balance Sheet
Earnings History for Alexza Pharmaceuticals Inc. (ALXA)
|
Expand Research on ALXA
| Next EPS Date | 8/14/13 *Est. | EPS Growth Rate | -3,175.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -46.3% | Revenue Growth Rate | -61.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/14/13 | Q113 | -$1.31 | -$0.45 | -$0.86 | $729K | $1M | N/A / N/A | N/A | -8% | Details | |
3/26/13  |
Q412 | -$0.65 | N/A | N/A | $729K | $1.88M | N/A / N/A | N/A | -1.3% | Details | |
| 11/7/12 |
Q312 | -$0.52 | N/A | N/A | $729K | $1.86M | N/A / N/A | N/A | -1.6% | Details | |
| 5/10/12 |
Q112 | -$0.04 | -$0.08 | +$0.04 | $1.88M | $1.3M | N/A / N/A | N/A | 0% | Details | |
| 11/30/99 | Q411 | -$0.13 | -$0.12 | -$0.01 | $1.88M | $5.8M | N/A / N/A | N/A | 0% | Details | |
| 11/7/11 |
 |
Q311 | -$0.19 | -$0.14 | -$0.05 | $1.3M | $670K | N/A / N/A | N/A | +222.8% | Details |
| 8/8/11 |
|
Q211 | -$0.13 | -$0.15 | +$0.02 | $1.26M | $430K | N/A / N/A | N/A | +262.8% | Details |
| 5/9/11 |
|
Q111 | -$0.14 | -$0.21 | +$0.07 | $1.26M | $730K | N/A / N/A | N/A | +196.6% | Details |
